Log BB Prediction Models Using TLC and HPLC Retention Values as Protein Affinity Data

Area of Science:

• Pharmacokinetics
• Medicinal Chemistry
• Computational Drug Design

Background:

• Drug penetration of the blood-brain barrier (BBB) is crucial for CNS drug efficacy and side effects.
• Understanding drug bioavailability in the CNS requires analyzing properties influencing BBB passage.
• The log BB parameter quantifies drug concentration across the BBB.

Purpose of the Study:

• To develop predictive regression models for drug penetration through the blood-brain barrier.
• To investigate the relationship between drug physicochemical properties and CNS bioavailability (log BB).
• To assess the impact of chromatographic data on model accuracy and robustness.

Main Methods:

• Construction of predictive models using physicochemical properties of active pharmaceutical ingredients.
• Application of multiple linear regression and MARSplines (a data mining technique).
• Integration of retention values from TLC and HPLC using serum albumin-modified stationary phases.

Main Results:

• High lipophilicity, ionization capacity, and low hydrogen bond formation capability were identified as key factors influencing log BB.
• Chromatographic data enhanced regression results and model robustness.
• A linear regression model with chromatographic parameters explained 85% of log BB variability; MARSplines explained 91%.

Conclusions:

• Chromatographic data integration improves the robustness of predictive regression models for biological barrier penetration.
• The study highlights the utility of combining physicochemical and chromatographic data for accurate BBB penetration prediction.
• Enhanced predictive models can aid in designing safer and more effective CNS-acting drugs.